ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy

Medicine & Life Sciences

• ABT 702 100%
• Adenosine 46%
• Adenosine Kinase 72%
• Animals 3%
• Cell Death 6%
• Diabetic Retinopathy 49%
• Down-Regulation 5%
• Enzymes 4%
• Experimental Diabetes Mellitus 9%
• glycosylated serum albumin 24%
• Inflammation 28%
• Nitrosative Stress 10%
• Oxidative Stress 5%
• Purinergic P1 Receptors 9%
• Real-Time Polymerase Chain Reaction 6%
• Retina 6%
• Staining and Labeling 5%
• Therapeutic Uses 6%
• Up-Regulation 5%
• Western Blotting 5%

Chemical Compounds

• Adenosine 45%
• Adenosine Kinase Inhibitor 91%
• Antagonist 5%
• Cell Death 6%
• Pharmacological Metabolism 4%
• Retinal 27%